Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Updated Altuviiio Label With Expanded Pediatric Data Confirming Highly Effective Bleed Protection in Children With Hemophilia
The US Food and Drug Administration (FDA) has updated the label for Altuviiio® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]...
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...
Geisinger enrolls first patient in amyloid cardiomyopathy trial
DANVILLE, Pa., May 10, 2024. Cardiologist Brendan Carry, MD, and a team of Geisinger physicians have enrolled the first patient in the U.S. into a cardiac...
Avoid Overheating Dangers When Recharging Medical Devices
SUNDAY, May 12, 2024 — If you use a medical device such as a blood glucose monitor or insulin pump, keeping it charged is a must. But devices...
Tips to Celebrating Mom on Her Day, Even When Dementia Intervenes
Women account for two-thirds of all Americans living with Alzheimer’s disease, which means this Mother’s Day will be bittersweet for many families...
Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization
For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled rehabilitation,...
Blood Pressure Down With Self-Monitoring of BP, Self-Titration of Medications
Blood pressure (BP) self-monitoring, together with self-titration of antihypertensive medications, is associated with a reduction in BP, according to a...
Lower Prevalence of Employment Seen for Survivors of Childhood Cancer
Adult survivors of childhood cancer have declines in employment and increases in health-related unemployment compared with the general population, according...
Breakthrough Gene Therapy Enables Infant Born Deaf to Hear
Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according...
Feds Announce New Measures to Monitor, Prevent Bird Flu
H5N1 avian flu is now infecting U.S. dairy cows and the federal government on Friday announced a myriad of initiatives aimed at preventing the virus' mutation...
His Cancer Journey Shows Health Dangers Firefighters Face
For 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape. Then a routine physical turned up anomalies in his blood...
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced positive...
There's a New Set of COVID Variants Called FLiRT: What You Need to Know
The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported. The...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...